ERM Power is refocusing on its core business by selling the US business and investing in the highest growth part of its Australian activities. We have increased our forecasts to reflect the accretive effect of the recent transactions and see more upside potential to the share price following the recent recovery as valuation multiples appear undemanding and the dividend yield is attractive.
Written by
ERM Power |
Refocusing on core business |
Business update |
Utilities |
31 October 2018 |
Share price performance
Business description
Next events
Analyst
ERM Power is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||
ERM Power is refocusing on its core business by selling the US business and investing in the highest growth part of its Australian activities. We have increased our forecasts to reflect the accretive effect of the recent transactions and see more upside potential to the share price following the recent recovery as valuation multiples appear undemanding and the dividend yield is attractive.
Year end |
Revenue (A$m) |
EBITDA |
EPS* |
DPS |
P/E |
Yield |
06/17 |
3,127 |
78.4 |
(10.5) |
7.0 |
N/A |
4.3 |
06/18 |
2,047 |
97.5 |
12.0 |
7.5 |
13.6 |
4.6 |
06/19e |
2,074 |
96.7 |
11.2 |
8.0 |
14.3 |
4.9 |
06/20e |
2,133 |
107.1 |
14.5 |
8.0 |
11.3 |
4.9 |
Note: *EPS is diluted and normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Refocusing on the core Australian business
Over the last few months, ERM Power has announced two transactions that refocus its activities on the core Australian business. First, in October, the company announced the sale of the US business for A$38m. We view the sale positively as 1) unitary margins of the US business have reduced significantly over the years; 2) we expected the US business to generate A$20m+ negative cash flow in FY19, with a large impact on the group’s cash flow; and 3) the May 2018 downgrade to the US business outlook resulted in the share price underperforming significantly. Second, ERM Power acquired Out Performers, which specialises in industrial energy productivity for large energy consumers, for A$12m (up to A$16m including earn-out). The acquisition will be immediately EPS accretive (we calculate a <5% positive impact on FY19 EPS on a full-year basis) and implies an FY18 P/E of 9.9x (7.5x excluding earn-out), a large discount to ERM Power’s c 14x FY19e P/E.
Our increased forecasts reflect M&A accretion
We have raised our forecasts for FY19-21 underlying net income from continuing operations by 6%, to reflect earnings accretion from the acquisition of Out Performers and cash inflow from the sale of the US business. The statutory net income (including discontinued operations) increases more, reflecting the removal of the losses from the US business (previously accounted as asset held for sale).
Valuation: More room for share price recovery
The share price has recovered c 20% since the lows in July following the recent announcements. However, the shares continue to trade on undemanding valuation multiples with c 14x FY19 P/E reducing to c 9x in FY21. The dividend yield is also attractive at 4.9% in FY19e/20e. Excluding energy solutions (currently loss-making and generating negative cash flow), our base case valuation increases marginally to A$2.4/share (from A$2.3/share) to reflect lower net debt as a result of the cash inflow from disposals. Including a valuation for the energy solutions business would increase the SOTP valuation to A$3.0/share (vs $2.9/share before). The cash inflow from the sale of the US business could add to growth projects and/or shareholders’ remuneration - we expect an update on this at H119 (February 2019).
Refocusing on core Australian business
Over the last few months, ERM Power has announced two transactions that refocus its activities on the core Australian business. ERM Power has exited the US market and acquired Out Performers in Australia.
Acquisition of Out Performers consistent with ERM Power’s strategy and is immediately EPS accretive
ERM Power has acquired Out Performers, which specialises in industrial energy productivity for large energy consumers, for A$12m debt-free (plus an earn-out over two years of up to A$4m). The acquisition strengthens the outlook for Energy Solutions, which is the division where we see the strongest growth potential.
Out Performers reported FY18 PBT of A$2.3m and we expect the acquisition will be immediately earnings accretive (equivalent to <5% positive impact on FY19 EPS on a full-year basis). On our calculations and using a 30% tax rate, the acquisition implies an FY18 P/E of 9.9x (7.5x excluding earn-out), at a large discount to ERM Power’s c 14x FY19 P/E, based on our forecasts.
Sale of US business removes large negative contribution to bottom line and cash flow
On 15 October ERM Power announced the sale of the US business, Source Power & Gas, to Direct Energy Business (owned by Centrica) for US$27m (A$38m). The sale is expected to complete by 30 November 2018. Net after-tax cash proceeds will be around US$23m (A$32m) from the sale after termination and transaction costs. ERM Power will book a loss of c A$8.5m to reflect the US business’ operating results to completion and wind-down and transition costs to June 2019.
We view the sale very positively as 1) ERM Power has struggled to improve the financial performance of this business over the past few years and unitary margins have reduced significantly; 2) we expected the US business to generate A$20m+ negative cash flow with a similar negative impact on group net income in FY19; and 3) the May 2018 downgrade in outlook resulted in a significant drop in the share price.
Balance sheet headroom increases post US disposal
ERM Power has previously discussed its capital deployment priorities. The company is currently implementing a A$20m share buyback programme, which will mostly affect FY19 (only A$2.8m shares bought in FY18). In addition, the company has indicated it has A$40m balance sheet headroom for growth projects (including acquisitions), of which only A$12m has been spent so far on the acquisition of Out Performers (A$16m including earn-out). Hence the cash inflow of A$32m from the sale of the US business (equivalent to 8% of ERM Power’s current market capitalisation) could add to growth projects and/or shareholders’ remuneration. We expect an update on this at the interim results in February 2019. At present, we include only the A$20m share buyback programme in our forecasts, so higher capex or improved shareholders’ remuneration would represent upside to our forecasts.
Forecasts changes: Earnings accretion
As set out in Exhibit 1, we have raised our FY19-21 forecasts for underlying net income from continuing operations by 6%, reflecting the earnings accretion from the acquisition of Out Performers and the cash inflow from the sale of the US business. The statutory net income (including discontinued operations) increases substantially, reflecting the removal of the losses from the US business (previously accounted as asset held for sale).
Exhibit 1: Forecasts changes
New forecasts |
Old forecasts (ex-US) |
% change |
||||||||||||
A$m |
2018 |
2019e |
2020e |
2021e |
2018 |
2019e |
2020e |
2021e |
2018 |
2019e |
2020e |
2021e |
||
Revenues |
2,047 |
2,074 |
2,133 |
2,164 |
2,047 |
2,068 |
2,124 |
2,151 |
0% |
0% |
0% |
1% |
||
EBITDA |
98 |
97 |
107 |
117 |
98 |
93 |
103 |
112 |
0% |
4% |
3% |
4% |
||
-Electricity retail AUS |
72 |
72 |
74 |
73 |
72 |
72 |
74 |
73 |
0% |
0% |
0% |
0% |
||
-Power generation |
44 |
40 |
41 |
42 |
44 |
40 |
41 |
42 |
0% |
0% |
0% |
0% |
||
-Energy solutions |
-4 |
1 |
8 |
18 |
-4 |
-3 |
5 |
13 |
0% |
-132% |
79% |
36% |
||
-Corporate |
-15 |
-16 |
-16 |
-17 |
-15 |
-16 |
-16 |
-17 |
0% |
0% |
0% |
0% |
||
EBIT |
67 |
63 |
72 |
82 |
67 |
61 |
70 |
78 |
0% |
4% |
4% |
4% |
||
PBT |
43 |
39 |
49 |
59 |
43 |
37 |
46 |
56 |
0% |
6% |
6% |
6% |
||
Underlying net income from continuing ops (ex LGC profits) |
30 |
28 |
35 |
42 |
30 |
26 |
33 |
39 |
0% |
6% |
6% |
6% |
||
Statutory net income incl. discontinued operations |
-81 |
29 |
65 |
42 |
-81 |
13 |
49 |
40 |
NA |
125% |
31% |
5% |
||
Source: ERM Power, Edison Investment Research
Valuation: Significant upside
The share price has recovered by c 20% since it fell in July following the announcement of the sale of the US business and supportive FY18 results. However, valuation multiples still appear undemanding compared with Australian small caps, with the stock trading at a P/E of c 14x in FY19 reducing to c 9x in FY21. The dividend yield is also attractive at 4.9% in FY19e/20e.
Excluding energy solutions (currently loss-making and generating negative cash flow) our base case valuation increases marginally to A$2.4/share (from A$2.3/share) to reflect lower net debt as a result of the cash inflow from disposals. Including a valuation for the energy solutions business, which has not reached break-even yet but has strong growth prospects in our view, would increase the SOTP valuation to A$3.0/share (vs $2.9/share previously). We value the various divisions mostly with DCF valuations, with an average WACC of c 11%. Our initiation note, Offering solutions to corporate energy challenges, published on 29 March 2018, includes more detail on our valuation methodology.
Key risks to our valuation and investment case are higher/lower supply and power-generation margins in Australia and higher/lower growth in energy solutions.
Exhibit 2: Financial summary
Accounts: IFRS, Year-end: June, A$m |
2016 |
2017 |
2018 |
2019e |
2020e |
2021e |
INCOME STATEMENT |
|
|
|
|
|
|
Total revenues |
2,691 |
3,127 |
2,047 |
2,074 |
2,133 |
2,164 |
Cost of sales |
(2,620) |
(3,049) |
(1,950) |
(1,977) |
(2,026) |
(2,047) |
Gross profit |
71 |
78 |
98 |
97 |
107 |
117 |
Exceptionals and adjustments |
(5) |
0 |
0 |
0 |
0 |
0 |
Depreciation and amortisation |
(25) |
(38) |
(30) |
(34) |
(35) |
(35) |
Reported EBIT |
40 |
41 |
67 |
63 |
72 |
82 |
Finance income/(expense) |
(23) |
(26) |
(24) |
(24) |
(23) |
(22) |
Other income/(expense) |
0 |
(0) |
0 |
0 |
0 |
0 |
Exceptionals and adjustments |
39 |
36 |
(34) |
2 |
30 |
0 |
Reported PBT |
57 |
51 |
9 |
41 |
79 |
59 |
Income tax expense (includes exceptionals) |
(22) |
(52) |
(90) |
(12) |
(15) |
(18) |
Reported net income |
36 |
(1) |
(81) |
29 |
65 |
42 |
Basic average number of shares, m |
242 |
244 |
244 |
238 |
233 |
233 |
Basic EPS (A$) |
0.15 |
(0.00) |
(0.33) |
0.12 |
0.28 |
0.18 |
DPS (A$) |
0.120 |
0.070 |
0.075 |
0.080 |
0.080 |
0.090 |
Adjusted EBITDA |
71 |
78 |
98 |
97 |
107 |
117 |
Adjusted EBIT |
46 |
41 |
67 |
63 |
72 |
82 |
Adjusted PBT |
23 |
15 |
43 |
39 |
49 |
59 |
Adjusted EPS |
0.08 |
(0.11) |
0.12 |
0.12 |
0.15 |
0.18 |
Adjusted diluted EPS (A$) |
0.08 |
(0.10) |
0.12 |
0.11 |
0.14 |
0.17 |
BALANCE SHEET |
|
|
|
|
|
|
Property, plant and equipment |
391 |
391 |
393 |
371 |
375 |
380 |
Goodwill |
0 |
0 |
0 |
0 |
0 |
0 |
Intangible assets |
79 |
89 |
89 |
89 |
89 |
89 |
Other non-current assets |
59 |
116 |
116 |
116 |
116 |
116 |
Total non-current assets |
529 |
597 |
599 |
577 |
580 |
586 |
Cash and equivalents |
192 |
245 |
80 |
135 |
178 |
194 |
Inventories |
22 |
42 |
28 |
28 |
29 |
29 |
Trade and other receivables |
331 |
361 |
236 |
239 |
246 |
250 |
Other current assets |
164 |
331 |
331 |
331 |
331 |
331 |
Total current assets |
709 |
979 |
676 |
734 |
784 |
804 |
Non-current loans and borrowings |
184 |
181 |
181 |
181 |
181 |
181 |
Other non-current liabilities |
161 |
287 |
253 |
262 |
262 |
262 |
Total non-current liabilities |
345 |
467 |
434 |
442 |
442 |
442 |
Trade and other payables |
367 |
464 |
297 |
331 |
339 |
343 |
Current loans and borrowings |
37 |
8 |
8 |
8 |
8 |
8 |
Other current liabilities |
18 |
70 |
70 |
70 |
70 |
70 |
Total current liabilities |
422 |
543 |
376 |
410 |
418 |
422 |
Equity attributable to company |
471 |
566 |
465 |
458 |
504 |
526 |
Non-controlling interest |
0 |
0 |
0 |
0 |
0 |
0 |
CASH FLOW STATEMENT |
|
|
|
|
|
|
EBIT |
40 |
41 |
67 |
63 |
72 |
82 |
Depreciation and amortisation |
16 |
53 |
30 |
34 |
35 |
35 |
Share based payments |
0 |
0 |
0 |
0 |
0 |
0 |
Other adjustments |
60 |
69 |
(119) |
0 |
0 |
0 |
Movements in working capital |
0 |
0 |
(18) |
31 |
1 |
(0) |
Interest paid / received |
3 |
3 |
4 |
1 |
2 |
3 |
Income taxes paid |
(0) |
(14) |
(24) |
(12) |
(15) |
(18) |
Cash from operations (CFO) |
120 |
152 |
(59) |
117 |
95 |
101 |
Capex |
(26) |
(40) |
(32) |
(32) |
(37) |
(39) |
Acquisitions & disposals net |
12 |
26 |
0 |
20 |
(2) |
(2) |
Other investing activities |
(9) |
(6) |
0 |
0 |
0 |
0 |
Cash used in investing activities (CFIA) |
(24) |
(20) |
(32) |
(12) |
(39) |
(41) |
Net proceeds from issue of shares |
0 |
0 |
(3) |
(17) |
0 |
0 |
Movements in debt |
(22) |
(24) |
0 |
0 |
0 |
0 |
Dividends paid |
(28) |
(23) |
(17) |
(18) |
(19) |
(20) |
Other financing activities |
(27) |
(33) |
(30) |
(15) |
5 |
(25) |
Cash from financing activities (CFF) |
(76) |
(79) |
(51) |
(50) |
(13) |
(45) |
Currency translation differences and other |
0 |
0 |
0 |
0 |
0 |
0 |
Increase/(decrease) in cash and equivalents |
20 |
53 |
(142) |
55 |
43 |
16 |
Currency translation differences and other |
0 |
(1) |
(23) |
0 |
0 |
0 |
Cash and equivalents at end of period |
192 |
245 |
80 |
135 |
178 |
194 |
Net (debt) cash |
(29) |
56 |
(109) |
(54) |
(11) |
5 |
Movement in net (debt) cash over period |
(29) |
85 |
(164) |
55 |
43 |
16 |
Source: Company data, Edison Investment Research
|
|
Research: Healthcare
Novartis’s US$2.1bn acquisition of Endocyte highlights the considerable potential upside that exists for Telix, if it can successfully develop its pipeline of molecularly targeted radiation (MTR) therapeutic and imaging products. It continues to make rapid progress across the portfolio, with the Atlab acquisition completed, Cardinal Health appointed as a sales and distribution agent for illumet (TLX591-CDx) in the US, a Phase I/II study of TLX101 in brain cancer initiated and the confirmatory Phase III study of TLX-250-CDx for imaging kidney tumours about to commence. Our valuation is unchanged at A$303m; value per share increases to A$1.43.